A decision in the case of the UK Anti-Doping (UKAD) v Miles Normandale has been published by the National Anti-Doping Panel (NADP).
On 20 September 2018 Miles Normandale, a registered player of Welsh Rugby Union, was selected for Out-of-Competition testing during a Cardiff RFC training session. The urine sample returned an Adverse Analytical Finding for the presence of clomifene, an anti-estrogenic substance listed within the hormone and metabolic modulators section of the Prohibited List. Clomifene is a Specified Substance, prohibited at all times, and Mr Normandale was subsequently charged with a breach of Anti-Doping Rule Article 2.1 for the Presence of a Prohibited Substance.
Mr Normandale admitted the Anti-Doping Rule Violation (ADRV) but contested his sanction on the grounds of intentionality. The NADP Tribunal consisting of Robert Englehart QC, Blondel Thompson and Professor Gordon McInnes found that UKAD did not establish that the ADRV was intentional and therefore imposed a period of ineligibility of 2 years.
As Mr Normandale promptly admitted the ADRV, his ban will run from 20 September 2018, the date of Sample collection, until midnight on 19 September 2020.
The full NADP decision can be accessed via the related links tab on the right-hand side.
The National Anti-Doping Panel (NADP) is the United Kingdom’s independent tribunal responsible for adjudicating anti-doping disputes in sport. It is operated by Sport Resolutions and is entirely independent of UK Anti-Doping, who are responsible for investigating, charging and prosecuting cases before the NADP.
